Sandra Gallach

The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients

Carlos Camps, Eloísa Jantus‐Lewintre, Andrea Cabrera‐Pastor et al. · Lung Cancer · 2010 · 50 citations · Full text

Medicine, Genetics, Oncology +11

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value

Sandra Gallach, Eloísa Jantus‐Lewintre, Silvia Calabuig‐Fariñas et al. · Oncotarget · 2017 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17

JunB Breakdown in Mid-/Late G ₂ Is Required for Down-Regulation of Cyclin A2 Levels and Proper Mitosis

Rosa Farrás, Véronique Baldin, Sandra Gallach et al. · Molecular and Cellular Biology · 2008 · 32 citations

Life Sciences, Cell Biology, Molecular Biology +17

A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer

Elena Sanmartín, Rafael Sirera, Marta Usó et al. · Annals of Surgical Oncology · 2013 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +15

Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients

Ning Dong, Andrea Moreno‐Manuel, Silvia Calabuig‐Fariñas et al. · Cancers · 2021 · 30 citations · Full text

Medicine, Immunology, Oncology +17